Clinical Trial Update: Retrospective & Prospective Observational Study of Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

View source ↗

Summary

Amgen sponsored a retrospective and prospective observational study of patients with idiopathic thrombocytopenic purpura (ITP); the trial status is completed an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Thrombocytopenic Purpura
• Thrombocytopenia

Snippet

Sponsor: Amgen | Conditions: Idiopathic Thrombocytopenic Purpura, Thrombocytopenia | Status: COMPLETED | Results posted: 2010-05-12